Q3 2025 net product revenue for ZORYVE® (roflumilast) was $99.2 million, a 122% increase compared to Q3 of 2024, and a 22% increase compared to ...
Shares in Arcutis Biotherapeutics (NASDAQ: ARQT) soared by almost 30% in trading to 10:30 a.m. ET today. The move comes after ...
Skin conditions with Parkinson’s disease are common and manageable. By paying attention to these symptoms, patients can ...
Arcutis Biotherapeutics surged as Q3 earnings beat forecasts and Zoryve sales boomed. Click for my updated look at ARQT stock ...
Arcutis achieved earlier-than-expected profitability and continues expanding Zoryve's label for broader indications. Read why ...
Everyday Health on MSN
5 DIY Tricks to Calm Scalp Psoriasis Irritation
For symptoms of scalp psoriasis, home treatments like olive oil, oatmeal, and apple cider vinegar may provide relief and make ...
Experts discuss the impact of severe eczema on children’s daily lives and the role of newer non-steroidal topical therapies ...
Skincare needs shift as children grow, according to Marisa Garshick, MD, FAAD, a board-certified dermatologist in New York City who is also the mother of tweens. Tweens benefit from learning the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback